91133-00-5 Usage
Chemical Class
Tetrahydroisoquinolines
Derived From
Salsolinol, a natural product found in fruits, vegetables, and fermented food products
Biological Activities
Anti-inflammatory: It exhibits properties that can reduce inflammation.
Antioxidant: It possesses antioxidant capabilities, which can neutralize free radicals and prevent oxidative damage.
Research Areas
Neurodegenerative Diseases: Investigated for its potential role in combating neurodegenerative diseases.
Addiction: Studied for its possible implications in addiction treatment.
Applications
Pharmaceuticals: Potential use in pharmaceutical formulations.
Organic Synthesis: Can serve as a precursor in organic synthesis processes.
Potential
Promising compound with diverse applications in medicine and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 91133-00-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,1,3 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 91133-00:
(7*9)+(6*1)+(5*1)+(4*3)+(3*3)+(2*0)+(1*0)=95
95 % 10 = 5
So 91133-00-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H13NO2/c1-8(13)12-6-5-10-9(7-12)3-2-4-11(10)14/h2-4,14H,5-7H2,1H3
91133-00-5Relevant academic research and scientific papers
Tyrosine Kinase Inhibitor And Uses Thereof
-
Paragraph 0622-0623, (2017/05/15)
Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, or their stereoisomers, which can be used as tyrosine kinase inhibitor. Also disclosed is a method for preparing the compound, a pharmaceutical composition and a kit comprising the compound, and uses of the compound. The compound can be used as tyrosine kinase inhibitor, or can be used to reduce or inhibit activity of EGFR or mutant thereof, such as EGFR mutant comprising T790M mutation, in a cell, or to treat and/or prevent a disease associated with overactivity of EGFR, such as cancer.
TETRAHYDROISOQUINOLINES AS ALPHA-2 ANTAGONISTS AND BIOGENIC AMINE UPTAKE INHIBITORS
-
, (2008/06/13)
The present invention provides a tetrahydroisoquinoline compound of the formula STR1 or a pharmaceutically acceptable salt thereof which is an antagonist for alpha-2 adrenoreceptors and/or which inhibits biogenic amine uptake.
